Phase I/II Study of Celebrex and EPO906 in Patients with Metastatic Colorectal Cancer (CEPO906AUS10).

Trial Profile

Phase I/II Study of Celebrex and EPO906 in Patients with Metastatic Colorectal Cancer (CEPO906AUS10).

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 29 Jun 2017

At a glance

  • Drugs Patupilone (Primary) ; Celecoxib
  • Indications Adenocarcinoma; Colorectal cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 23 Jun 2017 Planned End Date changed from 1 Jan 2017 to 1 Dec 2017.
    • 10 Jun 2017 Biomarkers information updated
    • 25 Mar 2015 Planned End Date changed from 1 Jan 2016 to 1 Jan 2017 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top